First-in-human evaluation of a no-alpha interleukin–2 mutein: safety and preliminary pharmacodynamic and clinical effect
Patricia Lorenzo-Luaces, Braulio Mestre Fernández, Iraida Caballero Aguirrechu, A. Reyes et al.
Journal
Frontiers in Immunology
Topics
CAR-T cell therapy research
article
First-in-human evaluation of a no-alpha interleukin–2 mutein: safety and preliminary pharmacodynamic and clinical effect
Patricia Lorenzo-Luaces, Braulio Mestre Fernández, Iraida Caballero Aguirrechu, A. Reyes, Sum Lai Lozada Chang, N. Alonso, Ana Fernández García, Kalet León, Ivis Mendoza Hernández, Daines Mariño de la Puente, M. A. Cardona, Tania Carmenate Portilla, Vilma Fleites Calvo, Gisela García‐Pérez, Jorge Luis García, Tania Crombet Ramos, G. Carvajal, C. Borges, J. Pérez, Elena García López, Nuris Ledón Naranjo, Yanelda García Vega, Alexis Alvárez Lobaina
article en
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in ImmunologyVol. 16
Institutions
Center of Molecular Immunology (Cuba) (CU), Hermanos Ameijeiras Hospital (CU), Cuban Neuroscience Center (CU), Instituto de Oncología y Radiobiología (CU)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
First-in-human evaluation of a no-alpha interleukin–2 mutein: safety and preliminary pharmacodynamic and clinical effect — Patricia Lorenzo-Luaces, Braulio Mestre Fernández, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS